Return to section

Driving syringes precisely, driving down cost

Ambulatory drug delivery devices infuse drugs into patients without loss of mobility. This is effective therapeutically and places the least restriction on patients but the existing device types are expensive; Volumetric Syringe Drivers and Pumps have high capital cost and Elastomerics disposables have high recurring costs.
 
Further costs arise when devices leave hospitals and become lost, or when the completion of delivery is unpredictable which extends healthcare visits. These cost factors restrict the application of otherwise beneficial ambulatory delivery devices.
 
In response to this problem, DANBY Medical and PDD have designed a new lower-cost Syringe Driver that eliminates the need for an expensive power train yet retains electronic control for precise drug delivery. The DANBY device is also economical to operate; using inexpensive syringes and without the need for batteries. It is compact, lightweight and has a long service life and its simplicity makes it easy for healthcare staff and home users to learn and use. Patented solutions ensure the safety of the self-powering technology.
 
DANBY and PDD continue to develop this technology to market. Visit DANBY Medical at www.danbymedical.com

Learn more about our expertise and work in Medical and Healthcare.


News & Insights

27/07/2017

PDD completes its transition to the 2016 version of ISO13485 for Medical Devices.

PDD has completed its planned transition to the latest version of this rigorous international quality assurance standard for medical devices, building on the success of earlier transitions and successful audits to the FDA 21CFR Part 820 in 2015.

18/02/2016

The Role of Human-Centred Design in Healthcare Reform and Transformation

All too often our health care is taken for granted, and we assume it will always be available to serve our community’s needs. The question is “How Healthy are our Healthcare Facilities to handle the diversity of services and to produce healthy outcomes for an expansive and unprecedented market of six (6) living generations – All distinctively different with a diverse set of needs and priorities?” According to Pew Research Centre in 2015, 75.3 million Millennials (18-34) surpassed the number of 74.9 million Baby Boomers (51-69), and Gen X (35-50) is projected to outnumber the Boomers by 2028.